An Overview of Diarrheagenic Escherichia coli Among Infants in Pakistan
DOI:
https://doi.org/10.31580/pjmls.v4iSpecial%20Is.1865Keywords:
Escherichia coli, Enterobacteriaceae, Diarrheal infections, Neonatal SepsisAbstract
Diarrhea is one of the leading public health problems in under established countries. Whereas in Pakistan, diarrheal issues are dried through empirical observation and hardly in which specific investigations are made. This article was premeditated to recognize the widespread strains of Escherichia coli among children of less than five years of age in Pakistan.
Escherichia coli is the commensal bacterium generally originates in human intestine after hours of birth. Escherichia coli generally remains safe and limited in intestinal lumen; though, in the incapacitated or immune-suppressed representatives, while gastrointestinal blockades are disturbed, still usual “nonpathogenic” strains of Escherichia coli are capable of being infectious. Constantly the strongest members of species can be responsive toward the harmful infections. One of very high alterative Escherichia coli clones that mutually have enhanced capability to cause an immense range of disease. Reviewing the studies pathogenic strains of Escherichia coli originate in new born babies. Which revealed a frightening issue in developing countries. The ratio of under 5 years children is suffering from diarrhea. In which from 1600 children in 2012 died due to diarrheal infection which increased yearly. In general, EPEC was the most frequent DEC pathotype in acute diarrheal children. Which exposed that EPEC, is emerging as a dominant diarrheal mediator in Pakistan. In this particular review we have explained the prevalent pathotypes of DEC. Frequently seen in infants present in Pakistan. To overcome on this problem the globally communal healthiness significance and determination to be emphasized. Which may reduce the pathogenic afflict of humans present in Pakistan and in South Asia.
References
Weintraub A. Enteroaggregative Escherichia coli: epidemiology, virulence and detection. Journal of medical microbiology. 2007 Jan 1;56(1):4-8.
Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nature reviews microbiology. 2004 Feb;2(2):123-40.
Duffell E, Espie E, Nichols T, Adak GK, De Valk H, Stuart JM. Investigation of an outbreak of E. coli O157 infections associated with a trip to France of schoolchildren from Somerset, England. Euro surveillance. 2003 Apr 1;8(4):81-6.
Rangel JM, Sparling PH, Crowe C, Griffin PM, Swerdlow DL. Epidemiology of Escherichia coli O157: H7 outbreaks, united states, 1982–2002. Emerging infectious diseases. 2005 Apr;11(4):603.
Lavigne JP, Marchandin H, Delmas J, Moreau J, Bouziges N, Lecaillon E, Cavalie L, Jean-Pierre H, Bonnet R, Sotto A. CTX-M β-lactamase-producing Escherichia coli in French hospitals: prevalence, molecular epidemiology, and risk factors. Journal of Clinical Microbiology. 2007 Feb 1;45(2):620-6.
Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. New England journal of medicine. 2001 Oct 4;345(14):1007-13.
Weintraub A. Enteroaggregative Escherichia coli: epidemiology, virulence and detection. Journal of medical microbiology. 2007 Jan 1;56(1):4-8.
Kampf G, Ostermeyer C, Heeg P, Paulson D. Evaluation of two methods of determining the efficacies of two alcohol-based hand rubs for surgical hand antisepsis. Applied and environmental microbiology. 2006 Jun 1;72(6):3856-61.
Lupp C, Ruby EG. Vibrio fischeri uses two quorum-sensing systems for the regulation of early and late colonization factors. Journal of bacteriology. 2005 Jun 1;187(11):3620-9.
Sousa CP. Pathogenicity mechanisms of prokaryotic cells: an evolutionary view. Brazilian Journal of Infectious Diseases. 2003 Feb;7(1):23-31.
Xie J, Foxman B, Zhang L, Marrs CF. Molecular epidemiologic identification of Escherichia coli genes that are potentially involved in movement of the organism from the intestinal tract to the vagina and bladder. Journal of Clinical Microbiology. 2006 Jul 1;44(7):2434-41.
Dobrindt U. (Patho-) genomics of Escherichia coli. International Journal of Medical Microbiology. 2005 Oct 5;295(6-7):357-71.
Ulett GC, Totsika M, Schaale K, Carey AJ, Sweet MJ, Schembri MA. UroPathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Current opinion in microbiology. 2013 Feb 1;16(1):100-7.
Russo TA, Johnson JR. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes and infection. 2003 Apr 1;5(5):449-56.
Mathers AJ, Peirano G, Pitout JD. Escherichia coli ST131: the quintessential example of an international multi resistant high-risk clone. Advances in applied microbiology. 2015 Jan 1; 90:109-54.
Tareen AM, Ullah K, Asmat TM, Samad A, Iqbal A, Mustafa MZ, Irshad A, ur Rahman S. Incidence of Diarrheagenic Escherichia coli Pathotypes in Children Suffering from Diarrhea in Tertiary Care Hospitals, Quetta, Pakistan. Pakistan Journal of Zoology. 2019 Dec 31;51(6):2015.
Russo TA, Johnson JR. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes and infection. 2003 Apr 1;5(5):449-56.
Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infectious disease clinics of North America. 2013 Dec 8;28(1):1-3.
Zilberberg MD, Shorr AF. Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000–2009. Infection Control & Hospital Epidemiology
Laupland KB, Church DL. Population-based epidemiology and microbiology of community-onset bloodstream infections. Clinical microbiology reviews. 2014 Oct 1;27(4):647-64.
Jackson LA, Benson P, Neuzil KM, Grandjean M, Marino JL. Burden of community-onset Escherichia coli bacteremia in seniors. The Journal of infectious diseases. 2005 May 1;191(9):1523-9.
Rodrigues C, Machado E, Ramos H, Peixe L, Novais Â. Expansion of ESBL-producing Klebsiella pneumoniae in hospitalized patients: a successful story of international clones (ST15, ST147, ST336) and epidemic plasmids (IncR, IncFIIK). International Journal of Medical Microbiology. 2014 Nov 1;304(8):1100-8.
World Health Organization. Oral health surveys: basic methods. World Health Organization; 2013.
Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB. Recent advances in understanding enteric pathogenic Escherichia coli. Clinical microbiology reviews. 2013 Oct 1;26(4):822-80.
Latif Baloch A. Prevalence of Multiple Drug Resistance among Avian Pathogenic E. coli Isolates from Commercial Poultry. Pak-Euro Journal of Medical and Life Sciences. 2019;2(4):83-8.
Turner SM, Scott-Tucker A, Cooper LM, Henderson IR. Weapons of mass destruction: virulence factors of the global killer enterotoxigenic Escherichia coli. FEMS microbiology letters. 2006 Oct 1;263(1):10-20.
Khatib LA, Tsai YL, Olson BH. A biomarker for the identification of swine fecal pollution in water, using the STII toxin gene from enterotoxigenic Escherichia coli. Applied microbiology and biotechnology. 2003 Dec;63(2):231-8.
Trabulsi LR, Keller R, Gomes TA. 10.321/eid0805. Typical and Atypical Enteropathogenic Escherichia coli. Emerging infectious diseases. 2002 May;8(5):508.
McDaniel TK, Jarvis KG, Donnenberg MS, Kaper JB. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proceedings of the National Academy of Sciences. 1995 Feb 28;92(5):1664-8.
Gupta A, Polyak CS, Bishop RD, Sobel J, Mintz ED. Laboratory-confirmed shigellosis in the United States, 1989–2002: epidemiologic trends and patterns. Clinical Infectious Diseases. 2004 May 15;38(10):1372-7.
Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nature reviews microbiology. 2004 Feb;2(2):123-40.
Cerna JF, Nataro JP, Estrada-Garcia T. Multiplex PCR for detection of three plasmid-borne genes of enteroaggregative Escherichia coli strains. Journal of clinical microbiology. 2003 May 1;41(5):2138-40.
Hlavsa MC, Roberts VA, Anderson AR, Hill VR, Kahler AM, Orr M, Garrison LE, Hicks LA, Newton A, Hilborn ED, Wade TJ. Surveillance for waterborne disease outbreaks and other health events associated with recreational water—United States, 2007–2008. MMWR Surveill Summ. 2011 Sep 23;60(12):1-32.
Rangel JM, Sparling PH, Crowe C, Griffin PM, Swerdlow DL. Epidemiology of Escherichia coli O157: H7 outbreaks, united states, 1982–2002. Emerging infectious diseases. 2005 Apr;11(4):603.
Muniesa M, Jofre J, García-Aljaro C, Blanch AR. Occurrence of Escherichia coli O157: H7 and other enterohemorrhagic Escherichia coli in the environment. Environmental science & technology. 2006 Dec 1;40(23):7141-9.
Snelling TL, Schultz R, Graham J, Roseby R, Barnes GL, Andrews RM, Carapetis JR. Rotavirus and the indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting. Clinical infectious diseases. 2009 Aug 1;49(3):428-31.
Bryce J, Boschi-Pinto C, Shibuya K, Black RE, WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death in children? The Lancet. 2005 Mar 26;365(9465):1147-52.
Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year? The lancet. 2003 Jun 28;361(9376):2226-34.
Bonacorsi S, Bingen E. Molecular epidemiology of Escherichia coli causing neonatal meningitis. International Journal of Medical Microbiology. 2005 Oct 5;295(6-7):373-81.
Darmstadt GL, Bhutta ZA, Cousens S, Adam T, Walker N, De Bernis L, Lancet Neonatal Survival Steering Team. Evidence-based, cost-effective interventions: how many newborn babies can we save. The Lancet. 2005 Mar 12;365(9463):977-88.
Stembera Z. Prospects for higher infant survival. In World health forum 1990; 11 (1): 78-84 1990.
